BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 10899931)

  • 1. Oncostatin M regulation of interleukin-6 expression in astrocytes: biphasic regulation involving the mitogen-activated protein kinases ERK1/2 and p38.
    Van Wagoner NJ; Choi C; Repovic P; Benveniste EN
    J Neurochem; 2000 Aug; 75(2):563-75. PubMed ID: 10899931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130.
    Hermanns HM; Radtke S; Haan C; Schmitz-Van de Leur H; Tavernier J; Heinrich PC; Behrmann I
    J Immunol; 1999 Dec; 163(12):6651-8. PubMed ID: 10586060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ciliary neurotrophic factor/leukemia inhibitory factor/interleukin 6/oncostatin M family of cytokines induces tyrosine phosphorylation of a common set of proteins overlapping those induced by other cytokines and growth factors.
    Boulton TG; Stahl N; Yancopoulos GD
    J Biol Chem; 1994 Apr; 269(15):11648-55. PubMed ID: 7512571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncostatin M and interleukin 6 inhibit cell cycle progression by prevention of p27kip1 degradation in HepG2 cells.
    Klausen P; Pedersen L; Jurlander J; Baumann H
    Oncogene; 2000 Jul; 19(32):3675-83. PubMed ID: 10951574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor subunit-specific action of oncostatin M in hepatic cells and its modulation by leukemia inhibitory factor.
    Wang Y; Robledo O; Kinzie E; Blanchard F; Richards C; Miyajima A; Baumann H
    J Biol Chem; 2000 Aug; 275(33):25273-85. PubMed ID: 10854424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncostatin M up-regulates tissue inhibitor of metalloproteinases-3 gene expression in articular chondrocytes via de novo transcription, protein synthesis, and tyrosine kinase- and mitogen-activated protein kinase-dependent mechanisms.
    Li WQ; Zafarullah M
    J Immunol; 1998 Nov; 161(9):5000-7. PubMed ID: 9794437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of Jak-Stat and MAPK2 pathways by oncostatin M leads to growth inhibition of human glioma cells.
    Halfter H; Friedrich M; Postert C; Ringelstein EB; Stögbauer F
    Mol Cell Biol Res Commun; 1999 May; 1(2):109-16. PubMed ID: 10356359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-redundant signal transduction of interleukin-6-type cytokines. The adapter protein Shc is specifically recruited to rhe oncostatin M receptor.
    Hermanns HM; Radtke S; Schaper F; Heinrich PC; Behrmann I
    J Biol Chem; 2000 Dec; 275(52):40742-8. PubMed ID: 11016927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M.
    Schrell UM; Koch HU; Marschalek R; Schrauzer T; Anders M; Adams E; Fahlbusch R
    J Neurosurg; 1998 Mar; 88(3):541-8. PubMed ID: 9488310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ICAM-1-induced expression of proinflammatory cytokines in astrocytes: involvement of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways.
    Lee SJ; Drabik K; Van Wagoner NJ; Lee S; Choi C; Dong Y; Benveniste EN
    J Immunol; 2000 Oct; 165(8):4658-66. PubMed ID: 11035109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncostatin M-mediated growth inhibition of human glioblastoma cells does not depend on stat3 or on mitogen-activated protein kinase activation.
    Halfter H; Stögbauer F; Friedrich M; Serve S; Serve H; Ringelstein EB
    J Neurochem; 2000 Sep; 75(3):973-81. PubMed ID: 10936178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 (IL-6) production by astrocytes: autocrine regulation by IL-6 and the soluble IL-6 receptor.
    Van Wagoner NJ; Oh JW; Repovic P; Benveniste EN
    J Neurosci; 1999 Jul; 19(13):5236-44. PubMed ID: 10377335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different epitopes are required for gp130 activation by interleukin-6, oncostatin M and leukemia inhibitory factor.
    Timmermann A; Pflanz S; Grötzinger J; Küster A; Kurth I; Pitard V; Heinrich PC; Müller-Newen G
    FEBS Lett; 2000 Feb; 468(2-3):120-4. PubMed ID: 10692570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential inhibition of IL-6-type cytokine-induced STAT activation by PMA.
    Terstegen L; Maassen BG; Radtke S; Behrmann I; Schaper F; Heinrich PC; Graeve L; Gatsios P
    FEBS Lett; 2000 Jul; 478(1-2):100-4. PubMed ID: 10922477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential roles of extracellular signal-regulated kinase-1/2 and p38(MAPK) in interleukin-1beta- and tumor necrosis factor-alpha-induced low density lipoprotein receptor expression in HepG2 cells.
    Kumar A; Middleton A; Chambers TC; Mehta KD
    J Biol Chem; 1998 Jun; 273(25):15742-8. PubMed ID: 9624172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncostatin M and the interleukin-6 and soluble interleukin-6 receptor complex regulate alpha1-antichymotrypsin expression in human cortical astrocytes.
    Kordula T; Rydel RE; Brigham EF; Horn F; Heinrich PC; Travis J
    J Biol Chem; 1998 Feb; 273(7):4112-8. PubMed ID: 9461605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncostatin M-specific receptor expression and function in regulating cell proliferation of normal and malignant mammary epithelial cells.
    Liu J; Hadjokas N; Mosley B; Estrov Z; Spence MJ; Vestal RE
    Cytokine; 1998 Apr; 10(4):295-302. PubMed ID: 9617575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncostatin M and leukemia inhibitory factor trigger overlapping and different signals through partially shared receptor complexes.
    Thoma B; Bird TA; Friend DJ; Gearing DP; Dower SK
    J Biol Chem; 1994 Feb; 269(8):6215-22. PubMed ID: 8119965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of chemokines by leukemia inhibitory factor, interleukin-6 and oncostatin M.
    Hartner A; Goppelt-Struebe M; Hocke GM; Sterzel RB
    Kidney Int; 1997 Jun; 51(6):1754-60. PubMed ID: 9186863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An antagonist for the leukemia inhibitory factor receptor inhibits leukemia inhibitory factor, cardiotrophin-1, ciliary neurotrophic factor, and oncostatin M.
    Vernallis AB; Hudson KR; Heath JK
    J Biol Chem; 1997 Oct; 272(43):26947-52. PubMed ID: 9341130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.